Trial Profile
A Randomized, Double-Blind, Four Treatment, Four period, Crossover Study, with Placebo, Tizanidine Immediate Release and Diphenhydramine to Study the Effect of Tizanidine Extended Release on Simulated Driving Performance, Cognitive, and Psychomotor Functioning
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Oct 2016
Price :
$35
*
At a glance
- Drugs Tizanidine (Primary)
- Indications Musculoskeletal pain
- Focus Therapeutic Use
- Sponsors Sun Pharma Advanced Research Company
- 05 Oct 2016 Status changed from recruiting to completed.
- 20 Sep 2016 New trial record